Two Cases of Diagnosis and Removal of Endobronchial Hamartoma by Cryotherapy via Flexible Bronchoscopy.
10.4046/trd.2014.76.3.141
- Author:
Jae Kyeom SIM
1
;
Jong Hyun CHOI
;
Jee Youn OH
;
Jae Young CHO
;
Eul Sun MOON
;
Hye Sook MIN
;
Byung Hyun LEE
;
Min Seon PARK
;
Gyu Young HUR
;
Sung Yong LEE
;
Jae Jeong SHIM
;
Kyung Ho KANG
;
Kyung Hoon MIN
Author Information
1. Division of Respiratory and Critical Care Medicine, Department of Internal Medicine, Korea University College of Medicine, Seoul, Korea. minkyunghoon@korea.ac.kr
- Publication Type:Case Report
- Keywords:
Bronchial Neoplasms;
Hamartoma;
Bronchoscopy;
Cryotherapy
- MeSH:
Airway Obstruction;
Aluminum;
Biopsy;
Bronchial Neoplasms;
Bronchoscopy*;
Cough;
Cryotherapy*;
Diagnosis*;
Dyspnea;
Early Diagnosis;
Electrocoagulation;
Follow-Up Studies;
Hamartoma*;
Hemoptysis;
Humans;
Pneumonia;
Yttrium
- From:Tuberculosis and Respiratory Diseases
2014;76(3):141-145
- CountryRepublic of Korea
- Language:English
-
Abstract:
Although endobronchial hamartoma is a rare benign tumor, most patients with endobronchial hamartoma have respiratory symptoms such as obstructive pneumonia, hemoptysis, cough, or dyspnea due to bronchial obstruction. It can cause irreversible post-obstructive pulmonary destruction, thus early diagnosis and treatment is very important. Recently, there have been cases of neodymium-doped yttrium aluminum garnet (Nd:YAG) laser and electrocautery procedures for bronchoscopic treatment of malignant or benign central airway obstruction with comparable therapeutic efficacy and few complications. Bronchoscopic cryotherapy is a newly developed technique for management of central airway obstruction. Moreover, it provides diagnostic methods with improving diagnostic yield and safety. We report two cases of endobronchial hamartoma, each diagnosed and definitively treated with bronchoscopic techniques. Endobronchial biopsy and removal was successfully performed by cryotherapy via flexible bronchoscopy without notable complications. Follow-up bronchoscopic examinations excluded residual or recurrent disease.
